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BACKGROUND: We investigated the relationship between idiopathic recurrent pregnancy loss (RPL) and genetic
polymorphisms in phase I and phase II detoxification genes which include CYP1A1, CYP2D6, GSTM1, GSTP1 and
GSTT1. METHOD: A case–control study comprised 160 females with RPL and 63 healthy controls with a success-
ful reproductive history. RESULTS: The CYP1A1 variant allele was present at frequencies of 0.61 and 0.44 in
cases and controls, respectively (odds ratio 5 1.93; P 5 0.023, 95% confidence interval 1.10–3.38). The CYP2D6
variant allele was present at a frequency of 0.17 in females with RPL, while in the control population the frequency
was 0.16. The GSTM1 and GSTT1 null genotypes were present at frequencies of 0.39 and 0.26 in RPL cases,
whereas in controls the frequencies were 0.37 and 0.17, respectively. The mutant GSTP1 frequencies in case and
control women were 0.38 and 0.40, respectively. We report a significant association of the CYP1A1*2A allele with
RPL which is confirmed by logistic regression analysis. No association was observed for the other polymorphisms
or in their combinations studied. CONCLUSIONS: The present study suggests the occurrence of the CYP1A1*2A
allele as a probable risk factor in idiopathic recurrent miscarriages.
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Introduction
An adequate amount of blood supply to the implantation site
is critical for establishing a successful pregnancy. The
maternal circulation through the placenta, however, is more
restricted during the first few weeks of gestation. The placen-
tal circulation rises sharply to its full level at 10–12 weeks
of gestation, i.e. towards the end of the first trimester
(Jauniaux et al., 2000). During this period, there is an
increased oxidative load in the placenta which facilitates
events such as embryonic differentiation and development
(Genbacev et al., 1997). However, the placental oxidative
stress may prove lethal to the developing embryo if there is
excessive oxidative load or inefficient antioxidant defences
which scavenge the load. The important role of maternal
total antioxidant status in idiopathic infertility is documented
(Polak et al., 2001).
It is well known that the risk of miscarriage is enhanced
by a variety of environmental as well as lifestyle factors such
as stress, smoking, alcohol consumption, etc. (Sokol et al.,
1980; Cnattingius et al., 1985). All these factors were known
to increase the oxidative stress through their activation
and elimination by members of detoxification systems. The
phase I detoxification activity, mostly carried out by the
cytochrome P450 (CYP) family of enzymes, is inevitably
associated with the generation of reactive oxygen species
(ROS) such as hydroxy radicals, superoxide, peroxides, etc.
Among the members of the CYP family, CYP1A1, Cyp1A2,
Cyp2C, CYP2D6, Cyp2E1, Cyp2F1, Cyp3A4, Cyp3A5,
Cyp3A7 and Cyp4B1 were found to be expressed in the pla-
centa during the first trimester, although the functional activi-
ties of Cyp3A and Cyp4B were not detected (Hakkola et al.,
1992). The importance of CYP1A1 and Cyp2E1 in relation to
pregnancy is substantiated further by the increased risk of
miscarriage with maternal smoking and alcohol consumption.
Experimental evidence indicates that during pregnancy, there
is increased expression of CYP2D6 (Wadelius et al., 1997),
which metabolizes about one-quarter of clinically important
medications. However, the exact role played by the enhanced
CYP2D6 levels in pregnancy remains obscure.
The glutathione-S-transferase (GST) family of enzymes,
being important members of phase II detoxification path-
ways, catalyse the conjugation of a variety of electrophilic
substances to glutathione, facilitating their elimination from
the body. Usually, the foreign substances activated by the
phase I reactions are acted upon by the GST enzymes. More-
over, GST enzymes also play an important role in regulation
of reduced glutathione levels, and thereby redox reserves of
the individual. Hence any decrease in the GST activity can
lead to accumulation of the products of phase I activity
which can cause severe damage. GST enzymes are believed
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to play a crucial role in female reproduction as suggested by
their presence in placenta and ovarian follicles in excessive
amounts (Zusterzeel et al., 1999). Among the various GST
enzymes, GSTP1 is reported to be the predominant isoform
in placenta, suggesting a possible role for this enzyme in
pregnancy (Knapen et al., 1999a,b).
Recurrent pregnancy loss (RPL) is defined as the incidence
of three or more spontaneous miscarriages. It is a hetero-
geneous condition involving several aetiological factors.
However, in about half of the cases, the exact reasons remain
obscure (Shawky et al., 2000). An association between RPL
and GST gene polymorphisms was suggested by recent
reports (Zusterzeel et al., 2000; Sata et al., 2003). In the light
of the above facts, we investigated the possible role played
by CYP1A1, CYP2D6, GSTM1, GSTP1 and GSTT1 gene
polymorphisms which are known to alter the activity or level
of expression of these enzymes in RPL cases from the South
Indian population.
Materials and methods
Patients
The present study was performed in 160 South Indian women with
three or more first trimester miscarriages. The number of pregnan-
cies lost varied from three to eight. All the females included are pri-
mary aborters with no live child. Routine diagnostic procedures
such as karyotyping of the partners, torch test, identification of anti-
phospholipid antibodies and hysteroscopic examination were used to
rule out known causes of pregnancy loss. None of them had any
pregnancy-related complications such as hypertension, thyroid
abnormalities, diabetes, etc. An ethnicity-matched control popu-
lation of 63 females with at least one successful pregnancy outcome
and without any history of spontaneous miscarriage or pregnancy-
associated complication was used in the present study for comparing
the results. Details regarding lifestyle habits as well as health status
were obtained from all these women after personal counselling by
the clinician. Informed written consent was obtained from all indi-
viduals. This study was approved by the Institutional Review Board.
DNA extraction
Genomic DNA was extracted from the EDTA-anticoagulated
peripheral blood by the salting-out procedure (Miller et al., 1988).
Genotype analysis
The CYP1A1*2A allele was detected by Msp I (New England
Biolabs, Inc., Beverly, MA) digestion of a 340 bp fragment after
PCR amplification using 50CAGTGAAGAGGTGTAGCCGCT and
50TAGGGAGTCTTGTCTCATGCCT primers. The CYP2D6*4
allele was detected by BstNI digestion of the PCR product amplified
using the 50GCCTTCGCCAACCACTCCG and 50AAATCCTGCT-
CTTCCGAGGC primer pair. The primers used for GSTM1 and
GSTT1 genotyping were 50CGCCATCTTGTGCTACATTGCCCG
and 50TTCTGGATTGTAGCAGATCA for GSTM1, and 50GCCCT-
GGCTAGTTGCTGAAG and 50GCATCTGATTTGGGGACCACA
for GSTT1. A 547 bp fragment from the NAT2 gene was co-ampli-
fied in each reaction as an internal control during GSTM1 and
GSTT1 genotyping. The primer pair used for NAT2 amplification
was GCTGGGTCTGGAAGCTCCTC and TTGGGTGATACATAC-
ACAAGGG. The wild and heterozygous null genotypes were scored
for a 230 bp fragment in the case of GSTM1 and a 112 bp product
for GSTT1. For GSTP1 genotyping, a 176 bp fragment obtained by
amplification using the ACCCCAGGGCTCTATGGGAA and TGA-
GGGCACAAGAAGCCCCT primer pair was sequenced with a Taq-
Dye deoxyterminator cycle sequencing kit (Applied Biosystems)
using an automated ABI 3770 sequencer.
The PCRs were carried out in a total volume of 25ml containing
10 mmol/l Tris–HCl (pH 8.3), 2.5 mmol/l MgCl2, 50 mmol/l KCl,
100mmol/l each dNTP, 0.5mmol/l each of the primer pair, 1.25 U
of AmpliTaq Gold DNA polymerase (Roche Molecular Biochemi-
cals) and 100 ng of template DNA. After pre-incubation at 948C for
5 min, the mixture was subjected to 35 cycles of 948C for 30 s, 598C
for 30 s (638C for CYP1A1 and 608C for CYP2D6) and 728C for
30 s. A final extension at 728C for 10 min was carried out to com-
plete extension of all DNA fragments.
Statistical analysis
The difference in frequencies between the case and control groups
was analysed for statistical significance at the 95% confidence inter-
val using Fisher’s two-tailed test. Odds ratios (ORs) were calculated
and reported within the 95% confidence limits. Unconditional multi-
nomial logistic regression analysis was performed with different
genotypes as well as genotype combinations as the independent fac-
tors, with the risk of RPL being the dependent variable. Factors
which do not possess a significant Wald statistic, but tend to
increase the P-value of the model, were selectively eliminated to
obtain the final model. The statistical analyses were performed
using SPSS for Windows (version 11.0) software. A P-value of
,0.05 was considered as significant in all the analyses.
Results
DNA samples obtained from 160 females with RPL and 63
females with a successful pregnancy history were analysed
for null genotypes in GSTM1 and GSTT1, and the variant
single nucleotide polymorphisms (SNPs) in GSTP1, CYP1A1
and CYP2D6. A post hoc power analysis according to
Lalouel and Rohrwasser (2002) was carried out to check the
strength of the study population in supporting the proposed
model. It was found that our population size had a reasonably
good power of 0.76 at a significance level of a ¼ 0.05 for
the CYP1A1 variant frequencies observed. The characteristics
of the study population are presented in Table I. The case
and control groups were similar with respect to age, ethnicity
and lifestyle habits. None of the women included in the pre-
sent study were either smokers or alcohol consumers. The
frequencies of various polymorphic alleles and genotypes
studied along with the relevant statistical parameters for
comparison are presented in Table II. None of the poly-
morphisms showed a correlation with age, as revealed by a
low Pearson’s correlation coefficient (P . 0.05; data not
shown). In the case of GSTM1 and GSTT1 genotyping,
Table I. Characteristics of the women included in the study
Cases (n ¼ 160) Controls (n ¼ 63)
Mean age in years (SD) 26.4 (4.26) 32.5 (6.7)
No. of miscarriages (range) 3–8 0
Smokers – –
Alcohol consumers – –
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the presence of at least one functional allele was scored for
the wild genotype. The homozygous and heterozygous
mutant frequencies were combined for CYP1A1, CYP2D6
and GSTP1 genotypes as the homozygous mutant frequencies
were smaller to study their significance. The frequencies of
GSTM1 nulls were 0.39 and 0.37 in the case and control
groups, while those for GSTT1 nulls were 0.256 and 0.17,
respectively. The mutant genotype frequencies for CYP1A1
were observed to be 0.606 in cases and 0.44 in controls; for
CYP2D6, 0.175 in cases and 0.16 in controls; and for
GSTP1, 0.381 in cases and 0.40 in controls. Among the var-
ious genotypes studied, the mutant CYP1A1 distribution was
significantly different between the case and control groups as
shown by a low Fisher’s two-tailed P-value of 0.023
(,0.05). When the distribution of various genotype combi-
nations and their significance was analysed, none of the
genotype combinations achieved association with the risk of
RPL at a 95% significant level (data not shown).This can
possibly be due to insufficient population size especially in
the case of CYP2D6 as the variant allele frequency is very
low. The results of multivariate logistic regression analysis
of the data are presented in Table III. The developed model
was significant at the 95% level (P ¼ 0.047) with a pseudo
R 2 value (Nagelkerke) of 0.106. Among the various factors
included in the model, the estimated logit coefficient [which
is ln (OR)] for CYP1A1 mutant genotype was found to be
significant as revealed by a significant Wald statistic of 6.7
(P ¼ 0.01). To validate the significance of CYP1A1 observed
in the multivariate logistic regression model, a bivariate
logistic regression with the Hosmer–Lemeshow goodness-of-
fit test was performed on CYP1A1 distribution, the results of
which supported the significance of CYP1A1 with an OR of
1.90 (P ¼ 0.03, data not shown).
Discussion
Apart from the established risk factors, detoxification mech-
anisms also play an important role in influencing the suc-
cess of pregnancy outcome. Studying the effect of phase I
as well as phase II gene polymorphisms in the context of
oxidative stress influencing embryonic growth, development
and hence the pregnancy outcome is gaining importance in
recent years (Hong et al., 2002). Many recent reports indi-
cate the importance of these enzyme systems in human
reproduction (Baranova et al., 1999; Hadfield et al., 2001;
Chen et al., 2002). However, no such study has been
reported so far in RPL cases from the Indian subcontinent.
Hence, we tried to study their relationship to the success of
pregnancy.
CYP1A1 is mainly involved in the oxidation of polycyclic
aromatic hydrocarbons which include compounds such as
benzopyrene, polychlorinated biphenyls, etc. (Hasler et al.,
1999), the common environmental toxicants. The Msp I poly-
morphism (*2A allele) in the CYP1A1 gene is known to
cause the high-inducible phenotype (Peterson et al., 1990;
Cosma et al., 1993), although the exact mechanism is not
known. Another member of the CYP family, CYP2D6, also
known as debrisoquine hydroxylase, is involved in the
metabolism of a number of drugs. The major polymorphisms
that are attributable to a decrease in CYP2D6 activity are the
2637deletion (*3) and G1934A transition (*4) (Bartsch et al.,
Table II. Distribution of GSTT1, GSTM1, GSTP1, CYP1A1 and CYP2D6 genotypes in women with RPL and the controls
Gene Allele Controls n ¼ 63a Cases n ¼ 160a Crude OR 95% CI P-value
No. (%) No. (%)
GSTT1 Present 52 (82.5) 119 (74.4)
Null 11 (17.5) 41 (25.6) 1.622 0.82–3.21 0.168
GSTM1 Present 40 (63.5) 97 (60.6)
Null 23 (36.5) 63 (39.4) 1.131 0.64–2.00 0.770
GSTP1 1a–1a 38 (60.3) 99 (61.9)
(A313G) 1a–1bb 16 (25.4) 50 (31.2)
1b–1b 9 (14.3) 11 (6.9) 0.934c 0.53–1.65 0.885
CYP2D6 wt/wt 53 (84.1) 132 (82.5)
(G1934A) wt/*4 10 (15.9) 25 (15.6)
*4/*4 0 (0) 3 (1.9) 1.121c 0.53–2.36 1.00
CYP1A1 wt/wt 35 (55.6) 63 (39.4)
(T6235C) wt/*2A 24 (38.1) 76 (47.5)
*2A/*2A 4 (6.3) 21 (13.1) 1.926c 1.10–3.38 0.023d
aTotal number of individuals tested.
b1b allele corresponds to the less active valine variant.
cParameters obtained after combining heterozygous and homozygous mutants.
dSignificant P-value (,0.05).
Table III. Logistic regression analysisa of the influence of different
genotypes and their combinations on RPL
Parameters OR P-value
Intercept 0.766
CYP2D6 (*4) 4.176 0.200
CYP1A1 (*2A) 2.456 0.010c
GSTM1 (Null) 1.076 0.866
GSTT1 (Null) 1.139 0.769
P1 ¼ Mhb 0.515 0.238
P1 ¼ Hzb 1.511 0.343
T1/M1 0.195 0.161
M1/P1 1.966 0.313
A1/2D6 6.913 0.112
aP-value of the final model: 0.047.
bMh: mutant homozygous; Hz: heterozygous.
cSignificant P-value.
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2000). From the data presented in Table II, we find no
association between the CYP2D6*4 allele and the risk of
RPL. However, a strong association between the occurrence
of the CYP1A1 variant allele and the risk of pregnancy loss
with an OR of 1.93 can be observed from the present data.
The increased level of CYP1A1 enzyme due to the poly-
morphic allele can lead to increased risk of oxidative damage
especially to the developing embryo. Moreover, during the
first trimester of pregnancy, the activities of enzymes such as
catalase, glutathione peroxidase and superoxide dismutase,
which remove the ROS, are very low in the placenta
(Hempstock et al., 2003). As a result, any kind of oxidative
stress imposed upon the developing embryo during the first
trimester cannot be handled efficiently by either the embryo
or the placenta, leading to severe damage. This can range
from DNA damage and chromosomal aberrations to lipid
peroxidation, cell lysis and fetal death.
In addition, recent reports indicate the presence of dioxins,
which are strong inducers of CYP1A1 expression, in human
follicular fluid (Tsutsumi et al., 1998). This suggests the
possibility of constant induction of CYP1A1 at low levels in
this tissue. The presence of a hyper-inducible allele in such
an instance may increase the levels of CYP1A1 to the extent
that it can cause severe damage to the fetus. The variant
CYP2D6*4 allele, which is responsible for the poor meta-
bolizer phenotype, does not appear to have a significant
relevance in pregnancy.
GSTs conjugate reduced glutathione to a number of ele-
crophilic substances including the products of phase I detoxi-
fication reactions, thereby facilitating their elimination from
the body. The deletion polymorphisms in GSTT1 and
GSTM1 were reported (Seidegard et al., 1988; Pemble et al.,
1994) to abolish their activity which, in turn, can lead to an
imbalance between the phase I and phase II activities,
increasing the risk of xenobiotic toxicity and oxidative stress.
The importance of GSTM1 null polymorphism as a possible
risk factor in pregnancy loss is validated through recent
studies carried out in other populations (Sata et al., 2003).
GSTP1 is the major isoform of GSTs found in the follicular
microenvironment (Knapen et al., 1999a,b). A functional
polymorphism at codon 105 (Ile! Val) in the GSTP1 gene
producing a less functional variant was reported to be associ-
ated with increased risk of RPL (Zusterzeel et al., 2000).
However, the present study failed to find an association
between the risk of RPL and the deletion polymorphism in
the GSTM1 and GSTT1 genes as well as the SNP in codon
105 of GSTP1 gene. From the results, GSTT1 and GSTM1
appear to play a minor role in pregnancy loss cases in the
South Indian population. These results absolutely do not con-
tradict the importance of decreased GST activity in RPL as
suggested by previous studies. The damage that can occur to
the early embryo due to decreased GST activity is oversha-
dowed by the severe oxidative threat produced by excessive
phase I, in particular CYP1A1, activity in the population
studied. A cohort study aimed at measurement of the ROS
in the follicular microenvironment in the background of
a mutant CYP1A1, however, is necessary to prove the
hypothesis.
To summarize, the present study revealed an association
between the presence of a variant allele of CYP1A1 and the
risk of recurrent early pregnancy loss. Other polymorphisms
analysed in the present study failed to show any association.
This study demonstrates the importance of detoxification
gene polymorphisms in the context of oxidative stress and a
threat to the survival of the embryo leading to pregnancy
loss. Moreover, the presented data also reveal the importance
of ethnicity in pharmacogenomic studies as the GSTP1 var-
iant was not found to be associated with RPL in the South
Indian population, unlike the case in many other populations.
In addition, this is the first study from the Indian subconti-
nent regarding the involvement of detoxification gene poly-
morphisms in RPL. A study using populations from other
parts of India will enable us to find the intra-regional vari-
ations and their relevance to RPL.
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